skip to main content
Show Results with:

Results 1 - 10 of 12  for Everything in this catalogue

results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside

Wittig, Burghardt et al.

Critical reviews in oncology/hematology. Volume 94:Issue 1 (2015, April); pp 31-44 -- Elsevier

Online access

2
Material Type:
Article
Add to My workspace

Genuine Immunomodulation With dSLIM

Kapp, Kerstin et al.

Molecular therapy -- Cell Press -- Volume: 3 Issue:; -- 2014

Online access

3
Material Type:
Article
Add to My workspace

740. The TLR9 Agonist EnanDIM® - Evaluation of New Enantiomeric Oligonucleotides for Cancer Immunotherapy In Vitro and In Vivo

Kapp, Kerstin et al.

Molecular therapy. Volume 24:Number S1 (2016, May); pp S292- -- Cell Press

Online access

4
Material Type:
Article
Add to My workspace

213. Treatment with MGN1601 Induces Immune Responses Against Tumor Associated Antigens in Patients with Renal Cell Carcinoma

Schmidt, Manuel et al.

Molecular therapy -- Cell Press -- Volume: 23 Issue: S1; -- 2015

Online access

5
Material Type:
Article
Add to My workspace

Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context

Kapp, Kerstin et al.

Immunity, inflammation and disease. Volume 4:Issue 4 (2016); pp 446-462 -- John Wiley & Sons Ltd

Online access

6
Material Type:
Article
Add to My workspace

Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vector1

Kobelt, Dennis et al.

Molecular oncology. Volume 8:Issue 3 (2014); pp 609-619 -- FEBS Press and John Wiley & Sons Ltd

Online access

7
Material Type:
Article
Add to My workspace

Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector

Kobelt, Dennis et al.

Molecular oncology -- Elsevier on behalf of the Federation of European Biochemical Societies -- Volume: 8 3; (pages 609-619) -- 2014

Online access

8
Material Type:
Article
Add to My workspace

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours

Weihrauch, Martin R. et al.

European journal of cancer. Volume 51:Issue 2 (2015, January); pp 146-156 -- Elsevier

Online access

9
Material Type:
Article
Add to My workspace

ITOC2 – 035. The immunotherapeutic TLR-9 agonist MGN1703 – Pharmacokinetic and pharmacodynamic data from healthy volunteers and cancer patients

Manuel, Schmidt et al.

European journal of cancer. Volume 51 (2015) Supplement 1; pp S12- -- Elsevier

Online access

10
Gene therapy of solid cancers : methods and protocols / edited by Wolfgang Walther, Ulrike Stein.
Material Type:
Book
Add to My workspace

Gene therapy of solid cancers : methods and protocols / edited by Wolfgang Walther, Ulrike Stein.

New York, NY : Humana Press, [2015].

Online access

Results 1 - 10 of 12  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Material type 

  1. Articles  (11)
  2. Books  (1)
  3. Refine further open sub menu

Creation date 

From To

Additional Features 

  1. Abstract  (7)
  2. No Abstract  (4)
  3. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Wittig, Burghardt
  2. Schmidt, Manuel
  3. Kapp, Kerstin
  4. Schroff, Matthias
  5. Volz, Barbara

Searching Remote Databases, Please Wait